International variation in managing locally advanced or recurrent rectal cancer: prospective benchmark analysis.
Quentin DenostM SolomonJean-Jacques TuechL GhoutiE CotteY PanisBernard LelongPhilippe RouanetJean-Luc FaucheronM JafariJérémie H LefevreE RullierA HeriotK AustinP LeeW BrownH Maillou-MartinaudH SavelB QuintardGuillaume BrocF Saillour-GlénissonPublished in: The British journal of surgery (2020)
This international benchmark trial has highlighted the differences in worldwide treatment of locally advanced and LRRC. Standardized care should improve outcomes for these patients.
Keyphrases
- locally advanced
- rectal cancer
- neoadjuvant chemotherapy
- squamous cell carcinoma
- radiation therapy
- phase ii study
- end stage renal disease
- healthcare
- ejection fraction
- newly diagnosed
- clinical trial
- chronic kidney disease
- palliative care
- study protocol
- prognostic factors
- type diabetes
- randomized controlled trial
- patient reported outcomes
- pain management
- phase iii
- phase ii
- combination therapy
- open label
- adipose tissue
- lymph node
- insulin resistance
- smoking cessation
- data analysis